Group sequential methods for interim monitoring of randomized clinical trials with time-lagged outcome
Anastasios A. Tsiatis, Marie Davidian

TL;DR
This paper develops a group sequential framework for interim analysis in clinical trials with time-lagged outcomes, improving early stopping decisions by efficiently using all available data including censored observations.
Contribution
It introduces a novel semiparametric approach for treatment effect estimation that accounts for censoring and covariates, enhancing early stopping decisions in clinical trials.
Findings
Estimates incorporating censoring lead to stronger evidence for early stopping.
Test statistics have independent increments, enabling standard software use.
Proposed methods outperform standard approaches in simulation studies.
Abstract
The primary analysis in two-arm clinical trials usually involves inference on a scalar treatment effect parameter; e.g., depending on the outcome, the difference of treatment-specific means, risk difference, risk ratio, or odds ratio. Most clinical trials are monitored for the possibility of early stopping. Because ordinarily the outcome on any given subject can be ascertained only after some time lag, at the time of an interim analysis, among the subjects already enrolled, the outcome is known for only a subset and is effectively censored for those who have not been enrolled sufficiently long for it to be observed. Typically, the interim analysis is based only on the data from subjects for whom the outcome has been ascertained. A goal of an interim analysis is to stop the trial as soon as the evidence is strong enough to do so, suggesting that the analysis ideally should make the most…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials · Advanced Causal Inference Techniques · Health Systems, Economic Evaluations, Quality of Life
